NCNMGF
XGN icon

Nano-Cap New Millennium Growth Fund’s Exagen XGN Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14M Buy
675,000
+90,000
+15% +$339K 2.41% 6
2026
Q1 		$1.75M Buy
585,000
+335,000
+134% +$1.3M 1.64% 12
2025
Q4 		$1.52M Buy
+250,000
New +$2.28M 1.3% 19

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's XGN Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Exagen (XGN) stake by 15% in Q2 2026, buying an estimated $339K and bringing the position to 675,000 shares worth $3.14M. The position accounts for 2.41% of the portfolio, ranked #6.

Nano-Cap New Millennium Growth Fund first reported a position in XGN in Q4 2025 and has held it in 3 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 675,000 shares of Exagen worth $3.14M as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund bought 90,000 Exagen shares in Q2 2026, an estimated $339K.
  • Exagen made up 2.41% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #6 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Exagen in Q4 2025 and has held it in 3 quarters since.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.